ASTEROID trial: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
(Redirected page to ASTEROID trial)
Line 1: Line 1:
The '''ASTEROID trial''' was a [[clinical trial]] published in [[2006]] that shows the effects of [[statin]]s (drugs that inhibit the enzyme [[HMG-CoA reductase]]) on [[atherosclerosis]]. Employing [[intravascular ultrasound]] (IVUS), they showed regression of the atherosclerotic plaques in response to a high dose of [[rosuvastatin]]<ref>Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. ''JAMA'' 2006;295:1556-65. PMID 16533939.</ref>
#Redirect [[ASTEROID trial]]
 
==References==
{{reflist|2}}
 
[[Category:Clinical trials]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 22:36, 17 September 2013

Redirect to: